What Is Parkinson’s Disease? Symptoms, Causes, Diagnosis, Treatment, and Prevention

What Is Parkinson’s Disease? Symptoms, Causes, Diagnosis, Treatment, and Prevention

What Is Parkinson’s Disease? Symptoms, Causes, Diagnosis, Treatment, and Prevention
Everyday Health

Parkinson’s disease is a movement disorder that happens when nerve cells (neurons) in a certain part of the brain are no longer making the chemical dopamine.

The condition is also sometimes known as paralysis agitans or shaking palsy.

The Parkinson’s Foundation estimates that nearly 90,000 Americans are diagnosed with Parkinson’s every year. But the true number of people who develop the disease may be much higher.

History of Parkinson’s Disease

Symptoms of Parkinson’s may appear in early medical texts, but the first clear medical description appears in an 1817 paper, “An Essay on the Shaking Palsy,” by James Parkinson, a London apothecary-surgeon and member of the Royal College of Surgeons.

Parkinson (1755–1824) observed what are now known as the classic symptoms of Parkinson’s disease, including tremors, rigidity, and postural instability. He theorized that the disease developed because of a problem in the brain’s medulla region.

Parkinson’s essay received little attention until 1861, when French neurologist Jean-Martin Charcot and his colleagues distinguished the disease from other neurological conditions and termed it “Parkinson’s disease.”

What Is Parkinsonism? Is It Different From Parkinson’s?

Parkinson’s disease is the most common cause of parkinsonism, a category of neurological diseases that cause slowed movement.

No quick or easy diagnostic tests exist for Parkinson’s disease, so a patient may receive an initial diagnosis of parkinsonism without a more specific condition being confirmed.

Classic Parkinson’s disease — referred to as idiopathic because it has no known cause — is the most common and most treatable parkinsonism, affecting up to 80 percent of people with parkinsonism. About 15 percent of parkinsonism is caused by atypical variants, such as multiple system atrophy, progressive supranuclear palsy, and others. These conditions can closely mimic idiopathic Parkinson’s disease, especially in the early years of symptoms. Parkinsonism can also be a result of other neurological diseases or injury, such as stroke or traumatic brain injury.


Signs and Symptoms of Parkinson’s Disease

Some of the most common motor symptoms are:

  • Tremors, or shaking movements
  • Bradykinesia, or slowed movement that all people with Parkinson’s experience
  • Rigidity, or stiffness
  • Postural instability, or issues with balance
  • Parkinsonian gait (also known as festinating gait) — walking while stooped over, or a combination of freezing and quickening of gait

Among the most common nonmotor symptoms are:

The primary symptoms of Parkinson’s disease — tremors, muscle stiffness, slow movement, and impaired balance — can vary from person to person depending on what subtype of Parkinson’s they have, but they generally get worse over time. The three Parkinson’s subtypes are:

  • Motor Only Symptoms are mainly motor (physical), with intact cognition and psychiatric function.
  • Psychiatric and Motor Symptoms are mainly psychiatric, with moderate motor deficits.
  • Cognitive and Motor Symptoms are a combination of cognition and motor.

Parkinson’s symptoms often begin on one side of the body and gradually affect both sides of the body, but they tend to be worse on the side they affected first.

Stages of Parkinson’s Disease

Neurologists usually describe the progression of Parkinson’s symptoms in stages, using the system known as the Hoehn and Yahr scale.

 These stages are:
  • Stage 1 Symptoms are seen on one side of the body only.
  • Stage 2 Symptoms are seen on both sides of the body. There’s no impairment of balance.
  • Stage 3 Balance impairment has begun. In this mild to moderate stage of the disease, the person is still physically independent.
  • Stage 4 This stage is marked by severe disability, but the person is still able to walk or stand unassisted.
  • Stage 5 The person requires a wheelchair or is bedridden unless assisted.

The signs and symptoms of Parkinson’s are divided into two categories: motor and nonmotor. Motor symptoms of Parkinson’s affect one’s movement, whereas nonmotor Parkinson’s symptoms are unrelated to movement.

Causes and Risk Factors of Parkinson’s Disease

Most cases of Parkinson’s disease are idiopathic, meaning the cause is unclear.

It’s widely believed that a person with Parkinson’s may be genetically vulnerable to the disease and that one or more unknown factors in the environment eventually triggers it.

Most of the symptoms of Parkinson’s disease come from the loss of neurons in an area of the brain called the substantia nigra.

Normally, the neurons in this part of the brain make the chemical messenger (neurotransmitter) dopamine, which allows communication with another area of the brain, the corpus striatum.

This communication helps produce smooth, purposeful movement. When the neurons in the substantia nigra die, the resulting loss of communication leads to the motor (movement-related) symptoms of Parkinson’s.

Although the cause of this cell death is unknown, many researchers believe that the cells are killed by clumped proteins called Lewy bodies.

What Are Lewy Bodies?

The affected neurons of people with Parkinson’s disease have been found to contain clumped proteins called Lewy bodies. Researchers aren’t yet sure why Lewy bodies form or what role they play in the disease, but Lewy bodies are believed to be toxic.

Lewy bodies are clumps of a protein called alpha-synuclein. Neurons can’t break down these protein clumps, which may lead to the death of these cells.

Some other theoretical causes of brain cell death in people with Parkinson’s disease include free-radical damage, inflammation, or toxins.

What Are the Risk Factors for Parkinson’s Disease?

Risk factors for Parkinson’s disease include:

Genetics

People with a first-degree relative (parent or sibling) with Parkinson’s are at an increased risk for the disease — possibly as much as 9 percent greater. Genetic risk factors (the presence of certain genes associated with Parkinson’s disease) are more commonly seen in early-onset Parkinson’s.

An estimated 15 to 25 percent of people with Parkinson’s disease have a family history of the disorder, but a condition called familial Parkinson’s, which has a known genetic link, is relatively rare.

Age

The average age of onset is 60, and the incidence rises with advancing age. About 5 to 10 percent of people have “early-onset” or “young-onset” disease, which begins before age 50.

Gender

The prevalence of Parkinson’s is around 1.5 times higher in men than women.

However, some recent studies suggest the gender differences may not be as stark as previously thought.

Pesticide Exposure

Exposure to some pesticides has been shown to raise the risk of developing Parkinson’s.

Problematic chemicals include organochlorine pesticides like DDT, dieldrin, and chlordane. Rotenone and permethrin have also been implicated.

Proximity to golf courses, which utilize a lot of pesticides in course management, has been linked to a greater risk of Parkinson’s Disease. In 2025, a JAMA Network Open study concluded that “the greatest risk of PD was found within 1 to 3 miles of a golf course and risk generally decreased with distance.”

Fungicide and Herbicide Exposure

Exposure to the fungicide maneb or the herbicides 2,4-dichlorophenoxyacetic acid (2,4-D), paraquat, or Agent Orange may raise the risk of Parkinson’s.

A 2023 study into Agent Orange exposure among Vietnam vets found rates of Parkinson’s disease to be 1.31 times higher than normal.

Head Injuries

Recurrent head injuries, particularly repetitive head injuries, may contribute to the development of Parkinson’s in some people. Traumatic brain injuries are also a major risk factor in developing Parkinson’s in later life.

Coffee and Smoking

People who drink coffee or smoke tobacco in moderation have been found to have a lower risk of Parkinson’s disease, due to the phenolic compounds in tobacco and coffee.

But while smoking could potentially lower the risk of Parkinson’s disease, it clearly increases the risk of lung cancer and cardiovascular disease, including heart attacks and stroke.

How Is Parkinson’s Disease Diagnosed?

There aren’t any specific tests to diagnose someone with Parkinson’s disease.

Doctors typically make a diagnosis based on the following:

  • Medical history
  • A neurological exam
  • Blood and lab tests (to rule out other disorders)
  • Brain scans (to rule out other disorders)
Sometimes, people who have a known inherited form of Parkinson’s disease can take a gene test to determine their risk of developing the disease.


Prognosis of Parkinson’s Disease

As Parkinson’s progresses, symptoms often worsen. While some people can respond well to therapy and have minimal disability issues, others can be more seriously affected over time, regardless of measures taken to slow the onset.

Although Parkinson’s isn’t considered a fatal disease itself, it can cause life-threatening complications that may shorten a person’s lifespan.

People living with Parkinson’s disease can have close to a normal life expectancy, but studies suggest that people with Parkinson’s have a lower 10-year survival than the general population.

Duration of Parkinson’s Disease

Once you have Parkinson’s, you can’t get rid of it. But there are many effective therapies to help control your symptoms and limit disability. Research shows that you can live many years with Parkinson’s disease.

Treatment and Medication Options for Parkinson’s Disease

For decades, doctors couldn’t treat Parkinson’s disease effectively and thought that it was a terminal illness. In the late 19th century, arsenic, morphine, hemlock, and cannabis were used to treat tremors.

By the 1940s and 1950s, neurosurgeons had begun to perform surgery on the basal ganglia of the brain, which resulted in improvements in Parkinson’s disease symptoms. While this surgery was sometimes effective, it was also risky — about 10 percent of patients died as a result of the operation.

The biggest advance in Parkinson’s treatment came in the 1960s. Researchers identified differences in the brains of people with Parkinson’s associated with low levels of the chemical dopamine, which plays a role in coordinated movement. This led to the development of medications that increase dopamine levels or improve dopamine processing in the brain.

There’s no cure for Parkinson’s, but a number of treatments can help manage the disease’s symptoms.

Medication Options

Medications for Parkinson’s disease fall into three general categories:

  • Medications that increase the level of the neurotransmitter dopamine in your brain
  • Medications that affect other neurotransmitters, to help control motor symptoms
  • Medications to help control nonmotor symptoms

Treating Parkinson’s disease with medication can be a balancing act between managing the disease and managing drug side effects.

Surgical Options

Deep brain stimulation surgery is an option for people with Parkinson’s disease whose symptoms are disabling despite best medication therapy. This is effective at treating severe tremors that impact a person’s ability to function or symptoms that fluctuate throughout the day in response to medication.

With this method, doctors implant electrodes in specific areas of the brain. The electrodes connect to a generator that’s implanted in the patient’s chest. The generator sends electrical pulses to the brain, which help reduce symptoms. By adjusting these electrical pulses, patients can often reduce their medication burden by up to 50 percent. Most people continue to take some dopamine-based medication even after surgery.

Another surgical option is MRI-guided focused ultrasound, which uses targeted ultrasound therapy to disrupt the brain network causing tremors. This can be very effective for people with bothersome tremor that may not be able to tolerate a more invasive procedure like deep brain stimulation.

Alternative and Complementary Therapies

Some people with Parkinson’s disease use complementary therapies to manage their symptoms.

These approaches may include:

  • Exercise Staying physically active can improve flexibility, strength, and mobility.
  • Diet A healthy diet can promote overall health for people with Parkinson’s disease.
  • Massage A massage may help lessen muscle tension and make you more relaxed.
  • Tai Chi This ancient type of Chinese exercise can improve balance, strength, and flexibility.
  • Yoga Yoga involves stretching and poses that can help with flexibility and balance.
  • Meditation Some people report that meditation can reduce pain and stress.
  • Feldenkrais Method These movement lessons have been shown to reduce depression and improve quality of life.

  • Alexander Technique This method focuses on muscle posture and balance.
  • Boxing Instructors at the nonprofit organization Rock Steady Boxing teach boxing exercises to help improve agility, muscular endurance, and hand-eye coordination among people with Parkinson’s. Find a class in your area.

Prevention of Parkinson’s Disease

Researchers don’t know of any proven ways to prevent Parkinson’s disease, but avoiding certain risk factors and adopting a healthy lifestyle may reduce your risk.

Some studies have shown a diet high in antioxidants, along with regular exercise, may play a role in preventing Parkinson’s. Other findings have suggested that compounds like caffeine (NoDoz), niacin (nicotinic acid), and nicotine (Thrive) may have a protective effect against Parkinson’s disease.

Researchers have studied various formulations of nicotine — including intranasal, transdermal, and chewing gum — to see whether they could help with Parkinson’s symptoms, but so far none has been found effective at slowing the progression of Parkinson’s.

African Americans and Parkinson’s Disease

African Americans remain underrepresented in Parkinson’s-related research studies, which may contribute to the discrepancies in estimates surrounding the number of African Americans affected by the disease.

A study published in 2021 showed that Black people with Parkinson’s were, on average, four years older at the time they received their diagnosis than white people with this condition.

The study also revealed racial disparities when it comes to diagnosis, treatment, survival, and medication use that negatively impact Black people compared with white people who have Parkinson’s.

For example, Black people were more likely to receive care for Parkinson’s through the emergency department than white people and were less likely to be taking medications for parkinsonism and mood disorders than white people.

These disparities likely result from factors such as health insurance status and access to medical care, among others.

Related Conditions and Causes of Parkinson’s Disease

Many conditions can cause symptoms that are similar to those of Parkinson’s disease, including the following:

  • Essential tremor
  • Normal pressure hydrocephalus
  • Dementia with Lewy bodies
  • Multiple system atrophy
  • Progressive supranuclear palsy
  • Corticobasal degeneration

The Takeaway

  • Parkinson’s disease causes symptoms such as tremors, muscle stiffness, slow movement, and balance issues that typically worsen over time.
  • Symptoms and progression can vary widely depending on the subtype of Parkinson’s disease.
  • Most cases are idiopathic, meaning the exact cause is unknown, though genetics and environmental factors are believed to play a role.
  • There is no proven way to prevent Parkinson’s disease, but a healthy lifestyle may help reduce risk.

FAQ

What are the four cardinal signs of Parkinson’s disease?
The primary symptoms of Parkinson’s disease — tremors, muscle stiffness, slow movement (bradykinesia), and impaired balance — can vary from person to person, but they generally get worse over time.
Anyone can get Parkinson’s, but there are certain risk factors for developing the disease: genetics, age (the average age of onset is 60), gender (Parkinson’s affects about 50 percent more men than women), and head injuries.
The average age of onset of Parkinson’s disease is 60, and the incidence rises with advancing age. About 5 to 10 percent of people have “early-onset” or “young-onset” disease, which begins before age 50.
Neurologists usually describe the progression of Parkinson’s symptoms in stages, using a system known as the Hoehn and Yahr scale. In the first stages, symptoms are seen on one side of the body only, and then eventually on both. In the later stages, balance impairment sets in, followed by severe disability.
No cure exists for Parkinson’s, but a number of treatments can help manage the disease’s symptoms. Prescription drugs are the most common, and they are usually the first type of treatment given. Other therapies include a surgical procedure called deep brain stimulation.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Statistics. Parkinson’s Foundation. 2026.
  2. Goetz CG et al. The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies. Cold Spring Harbor Perspectives in Medicine. September 2011.
  3. Rajput A et al. Parkinsonism. Merck Manual Consumer Version. February 2024.
  4. Understanding Parkinsonism. Parkinson’s Foundation. 2026.
  5. Cash TV et al. Replication and Reliability of Parkinson’s Disease Clinical Subtypes. Parkinsonism and Related Disorders. May 22, 2024.
  6. Stages of Parkinson’s. Parkinson’s Foundation.
  7. Campellone JV. Substantia Nigra and Parkinson Disease. MedlinePlus. March 2024.
  8. What Is Parkinson’s? Parkinson’s Foundation. 2026.
  9. Lewy Body Dementia: Causes, Symptoms, and Diagnosis. National Institute on Aging. January 2025.
  10. Parkinson’s Disease: Challenges, Progress, and Promise. National Institute of Neurological Disorders and Stroke. February 2025.
  11. Young-Onset Parkinson’s. Parkinson’s Foundation.
  12. Cattaneo C et al. Sex Differences in Parkinson’s Disease: A Narrative Review. Neurology and Therapy. December 2024.
  13. Arellano M et al. Identification of Pesticides Associated With an Increased Risk of Parkinson’s Disease Using a Multi-Screen Approach. Environmental International. January 2026.
  14. Krzyzanowski B et al. Proximity to Golf Courses and Risk of Parkinson Disease. JAMA Network Open. May 2025.
  15. Song S et al. Effects of Defoliant Exposure and Medication Use on the Development of Parkinson's Disease in Veterans. Age and Ageing. October 2023.
  16. Balabandian M et al. Traumatic Brain Injury and Risk of Parkinson's Disease: A Meta-Analysis. Acta Nerologica Belgica. October 2023.
  17. Hong SW et al. Smoking, Coffee Intake, and Parkinson’s Disease: Potential Protective Mechanisms and Components. Neurotoxicology. December 2024.
  18. Parkinson’s Disease. Mayo Clinic. September 27, 2024.
  19. Parkinson’s Disease. National Institute of Neurological Disorders and Stroke. March 8, 2023.
  20. HG Seo et al. Ten-Year Relative Survival From the Diagnosis of Parkinson's Disease: A Nationwide Database Study. Journal of the American Medical Association. August 2021.
  21. Living With Parkinson’s. Parkinson’s Foundation. 2026.
  22. Goetz CG et al. The History of Parkinson’s Disease: Early Clinical Descriptions and Neurological Therapies. Cold Spring Harbor Perspectives in Medicine. September 2011.
  23. Berland R et al. Effects of the Feldenkrais Method as a Physiotherapy Tool. International Journal of Environmental Research and Public Health. October 2022.
  24. Seo HG et al. Ten-Year Relative Survival From the Diagnosis of Parkinson’s Disease: A Nationwide Database. Journal of the American Medical Association. August 2021.
  25. Aamodt W et al. Racial and Ethnic Disparities in Parkinson Disease. Neurological Clinical Practice. March 2023.
  26. Xie T et al. Disparities in Diagnosis, Treatment and Survival Between Black and White Parkinson Patients. Parkinsonism and Related Disorders. April 2021.
Sneha Mantri

Sneha Mantri, MD, MS

Medical Reviewer

As the Parkinson’s Foundation first-ever chief medical officer, Sneha Mantri, MD, MS, leads medical and clinical care efforts, guiding the Foundation’s care portfolio and strategy to ensure impactful, sustainable initiatives.

Dr. Mantri is a practicing movement disorders specialist with extensive training and experience. She completed her medical education at Columbia University, residency at the University of Virginia, and a movement disorders fellowship at the University of Pennsylvania and Philadelphia VA Medical Center.

She brings her patient-centered philosophy to the Parkinson's Foundation, emphasizing that people come before their diagnosis and that Parkinson’s care must be personalized.

Throughout her career, Mantri has focused on building collaborations and expanding outreach to rural communities while raising Parkinson’s awareness in the medical field.

She developed collaboration with the Margolis Institute for Health Policy through the Duke Clinical Leadership Program in 2024 and participates in a PBS-NC panel discussion for her integrated, interprofessional care model.

She serves as a Macy Faculty Scholar, currently working to expand humanistic and community-engaged practice nursing, and physical and occupational therapy. She has also been leading THRIVE-PD since 2019, an early-intervention team-based care model for people with Parkinson's across the Carolinas.

erin-archer-kelser-bio-final

Erin Archer Kelser, RN

Author

Erin Archer Kelser, RN, is a freelance health writer and registered nurse in the Tucson, Arizona, area. She has written for the Institut Pasteur, AuntMinnie.com, and the Catholic Health Association. She has a degrees in both English and nursing.